一步法18F标记的PSMA三氟硼酸盐探针用于肿瘤成像的临床前评价
研究设计并评估了8种经一步19F-18F同位素交换标记的三氟硼酸盐PSMA靶向探针,在LNCaP荷瘤小鼠中行PET/CT与生物分布研究,并与18F-DCFPyL比较。所有探针具有纳摩尔亲和力、高摩尔活度标记和高中瘤摄取;含萘丙氨酸连接基的多数衍生物出现明显胃肠道排泄,而双三氟硼酸盐-谷氨酸标记部分者肿瘤摄取高、背景低且无肝或胃肠道蓄积。结论认为此类探针一步标记简便,肿瘤摄取和对比度与18F-DCFPyL相似,是有前景的前列腺癌成像候选。
要点
- 8种三氟硼酸盐PSMA探针均可一步19F-18F标记,具纳摩尔亲和力与高中瘤摄取。
- 含萘丙氨酸连接基的多数衍生物经胃肠道明显排泄。
- 双三氟硼酸盐-谷氨酸标记探针肿瘤摄取高、背景低且无肝或胃肠道蓄积。
核心结论
- 三氟硼酸盐PSMA靶向探针一步标记简便,肿瘤摄取高、对比度与18F-DCFPyL相似,是前列腺癌成像的有前景候选。
研究设计与样本
- 制备8种三氟硼酸盐构建体,经一步19F-18F同位素交换标记后注入LNCaP荷瘤小鼠,设或不设阻断对照。
- 注射后1小时采集PET/CT图像与生物分布数据,并与18F-DCFPyL在同一小鼠品系和肿瘤模型比较。
主要发现
- 所有探针呈纳摩尔亲和力,以高摩尔活度获得良好放射化学产率,在LNCaP移植瘤中肿瘤摄取高并从非靶器官清除。
- 含萘丙氨酸连接基的多数衍生物出现明显胃肠道排泄。
- 含该连接基与双三氟硼酸盐-谷氨酸标记部分的探针肿瘤摄取高、背景活性低,且无肝或胃肠道蓄积。
临床怎么用
- 临床前结果支持进一步开发一步18F标记的三氟硼酸盐PSMA探针用于前列腺癌PET成像。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
After the identification of the high-affinity glutamate-ureido scaffold, the design of several potent 18F- and 68Ga-labeled tracers has allowed spectacular progress in imaging recurrent prostate cancer by targeting the prostate-specific membrane antigen (PSMA). We evaluated a series of PSMA-targeting probes that are 18F-labeled in a single step for PET imaging of prostate cancer. Methods: We prepared 8 trifluoroborate constructs for prostate cancer imaging, to study the influence of the linker and the trifluoroborate prosthetic on pharmacokinetics and image quality. After 1-step labeling by 19F-18F isotopic exchange, the radiotracers were injected in mice bearing LNCaP xenografts, with or without blocking controls, to assess specific uptake. PET/CT images and biodistribution data were acquired at 1 h after injection and compared with 18F-DCFPyL on the same mouse strain and tumor model. Results: All tracers exhibited nanomolar affinities, were labeled in good radiochemical yields at high molar activities, and exhibited high tumor uptake in LNCaP xenografts with clearance from nontarget organs. Most derivatives with a naphthylalanine linker showed significant gastrointestinal excretion. A radiotracer incorporating this linker with a dual trifluoroborate-glutamate labeling moiety showed high tumor uptake, low background activity, and no liver or gastrointestinal track accumulation. Conclusion: PSMA-targeting probes with trifluoroborate prosthetic groups represent promising candidates for prostate cancer imaging because of facile labeling while affording high tumor uptake values and contrast ratios that are similar to those obtained with 18F-DCFPyL.
引用
- Kuo HT, Lepage ML, Lin KS, et al. One-Step 18F-Labeling and Preclinical Evaluation of Prostate-Specific Membrane Antigen Trifluoroborate Probes for Cancer Imaging. J Nucl Med. 2019. PMID: 30737299. doi:10.2967/jnumed.118.216598
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。